WTO Price Transparency Talks Face Resistance From Developed Countries
Last week the World Trade Organization’s TRIPS Council discussed transparency in medicine pricing, including R&D costs.
You may also be interested in...
Following on from moves to push price transparency on to the global agenda, Italy is poised to pass a decree that would oblige companies to disclose public R&D funding.
EU countries should use a milestone World Health Organization resolution calling for more transparency on net medicine prices to help secure better access to medicine, says the Valletta group.